Bank of Montreal’s Fulgent Genetics FLGT Stock Holding History

Bank of Montreal’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,000	Closed	-$310K	–	5164
2020 Q4	$310K	Buy	+5,000	New	+$209K	﹤0.01%	2975

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's FLGT Position: Q3 2022 in Review

Bank of Montreal sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 3,933 shares — an estimated $225 sold.

Bank of Montreal first reported a position in FLGT in Q3 2016 and held it in 12 quarters. The position peaked at $4.26M in Q2 2020. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

Bank of Montreal reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
Bank of Montreal sold 3,933 Fulgent Genetics shares in Q3 2022, an estimated $225.
Bank of Montreal first reported a position in Fulgent Genetics in Q3 2016 and held it in 12 quarters.
Bank of Montreal's Fulgent Genetics position peaked at $4.26M in Q2 2020.
235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.